Condition
Fatigue in Cancer Survivors
Total Trials
4
Recruiting
2
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Recruiting2
Terminated1
Active Not Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT06710548Not ApplicableRecruiting
REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors
NCT06754722Not ApplicableRecruiting
Decentralized Clinical Trial of Effectiveness of EnergyPoints App in Cancer Survivors
NCT07237503Not ApplicableActive Not Recruiting
THE EFFECT OF CALISTHENIC EXERCISES ON FATIGUE AND EXERCISE ATTITUDES IN PATIENTS WITH LUNG CANCER
NCT02452710Not ApplicableTerminatedPrimary
Harnessing the Effect of an Open-Label Placebo on Fatigue in Cancer Survivors
Showing all 4 trials